- Rating
- 1
- Confidence
- 4
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 1
Read review
Paper summary
This paper presents MM-HAGT, a hierarchical graph Transformer for pathological staging that jointly models gigapixel whole-slide images (WSIs) and partially observed clinical data. The method comprises: (1) an adaptive WSI graph encoder with a learnable semantic gate that suppresses background patches and edge weighting combining a Gaussian spatial kernel with cosine feature similarity; (2) multi-query hierarchical attention that aggregates patch features into region- and slide-level representations, combined via gated cross-level fusion; and (3) a missing-aware clinical encoder (observation masks, reliability gating, a learnable missing-information prior, modality dropout, and an auxiliary classification head) whose token conditions WSI representations through self-attention. The model is evaluated with five-fold cross-validation on TCGA-COAD (461 WSIs) and TCGA-KICH (113 WSIs), reporting improvements in Accuracy, F1, and AUC over six baselines (SSM, DTFD-MIL, MambaMIL, HDMIL, HEAT, CLAM), along with ablations of three modules and attention heatmap visualizations.
Critical strengths
-
Genuine and clinically relevant motivation. Fusing WSIs with structured clinical records while explicitly handling missing fields addresses a real pain point in pathology workflows. The missing-aware conditioning design is more principled than simple imputation with late fusion, and the overall framework is internally coherent.
-
Reasonably sound evaluation protocol. Patient-level splitting prevents leakage, five-fold cross-validation is used, and checkpoint selection relies on validation data. The authors also show welcome restraint in interpreting attention heatmaps and ROC curves (explicitly stating no pathologist validation and no calibration claims).
Critical weaknesses
- The core contribution lacks an evidence chain. The title, abstract, and contributions all emphasize conditioning on incomplete clinical data, yet the ablation study covers only pathology-side modules — the clinical encoder, modality dropout, and reliability gate are never ablated. Moreover, no multimodal baseline and no WSI-only variant of the model are compared, so the performance gains cannot be attributed to the claimed mechanism. In effect, the paper's central claim remains unverified.
- Questionable reliability of the results. The anomalously large AUC gain (+11.5 points) together with an anomalously small variance (±0.5) strongly suggests inconsistent metric computation across methods. Combined with an undefined ablated module (GAPE) and duplicated references listing the same paper twice (Chan et al. 2023a/b and Dong et al. 2025a/b are the same works), the overall rigor is concerning.
Questions for authors
- How exactly is AUC computed (macro-averaged one-vs-rest?). Is the identical evaluation code used for all methods and all metrics? Can you provide paired significance tests?
- Please define GAPE and indicate where it sits in the architecture — it appears to be absent from the main text.
- What are the actual missing rates of each clinical field in the two cohorts? How does performance vary under artificially imposed missing rates (e.g., 0–80%), compared against simple imputation or mean-fill clinical encoders?
- What is the performance of the model without the clinical branch (WSI-only)?